The Japanese Journal of Pharmacology · 2002 · 15 citations · 12 references
MedicineImmunologyPharmacologyImmunopathologyImmunopharmacologyInflammationEosinophilic DisordersImmunomodulatory DrugsEosinophil AdhesionEosinophil RecruitmentEosinophil RegulationEosinophil-mediated InflammationEosinophil-mediated ResponsesEosinophilic Disease TherapyEosinophilic Infiltrates
The inhibitory effect of olopatadine, a new antiallergic drug, on antigen-induced eosinophil infiltration and its mechanisms were examined using the local sensitized rat allergic rhinitis model and isolated IL-5-stimulated rat peritoneal eosinophils. Olopatadine dose-dependently inhibited antigen-induced eosinophil infiltration in the nasal mucosa. Olopatadine dose-dependently repressed the IL-5-induced expressions of CD11a/CD18 (LFA-1) and CD11b/CD18 (Mac-1) on rat peritoneal eosinophils. However, olopatadine had no effect on IL-5-induced CD49d/CD29 (VLA-4) expression. These results suggest that olopatadine may inhibit antigen-induced eosinophil infiltration through repression of LFA-1 and Mac-1 expression.
12
Leukocyte-endothelial adhesion molecules
Leukocyte-endothelial adhesion molecules
Motohiro Ebisawa, Bruce S. Bochner, Steve N. Georas et al. · The Journal of Immunology · 1992 · 190 citations
Giorgio Ciprandi, Caterina Pronzato, Giovanni Passalacqua et al. · Journal of Allergy and Clinical Immunology · 1996 · 107 citations